[1] 黄陈, 戎泽印. 结直肠癌诊治新进展[J]. 蚌埠医学院学报, 2018, 43(10): 1293.
[2] 张政, 李鹏, 张澍田. 中国结直肠癌筛查的研究历史现状与展望[J]. 中国实用内科杂志, 2018, 38(9): 777.
[3] 杨伟兴, 喻玉, 肖王, 等. 结肠癌中NMNAT2、p53的表达及三者相关性研究[J]. 现代生物医学进展, 2019, 19(14): 2735.
[4] TORRICELLI F, SAXENA A, NUAMAH R, et al. Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy[J]. Eur J Cancer, 2020, 132: 104. doi: 10.1016/j.ejca.2020.03.002
[5] ZHAO X, WANG Q, LIN F, et al. RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1(UQCRC1)[J]. Med Sci Monit, 2019, 25: 4982. doi: 10.12659/MSM.917375
[6] 谭杨波, 廖桂红, 陈龙, 等. 肿瘤标志物在结直肠癌诊断应用中的研究新进展[J]. 卫生职业教育, 2019, 37(6): 158.
[7] 国家卫生计生委医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J]. 中华普通外科学文献, 2018, 38(10): 1089.
[8] HU X, LI YQ, LI QG, et al. ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer[J]. EBioMedicine, 2018, 35: 178. doi: 10.1016/j.ebiom.2018.08.003
[9] TESTA U, PELOSI E, CASTELLI G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells[J]. Med Sci (Basel), 2018, 6(2): 31.
[10] 刘晓雪, 宇传华, 周薇, 等. 中国近30年间结直肠癌死亡趋势分析[J]. 中国癌症杂志, 2018, 28(3): 177.
[11] SHAN W, LI J, XU W, et al. Critical role of UQCRC1 in embryo survival, brain ischemic tolerance and normal cognition in mice[J]. Cell Mol Life Sci, 2019, 76(7): 1381. doi: 10.1007/s00018-019-03007-6
[12] KULAWIEC M, ARNOUK H, DESOUKI MM, et al. Proteomic Analysis of Mitochondria-to-Nucleus Retrograde Response in Human Cancer[J]. Cancer Biol Ther, 2006, 5(8): 967. doi: 10.4161/cbt.5.8.2880
[13] WANG X, ZHI Q, LIU S, et al. Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach[J]. Sci Rep, 2016, 6(1): 38871. doi: 10.1038/srep38871
[14] WANG Q, LI M, GAN Y, et al. Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer[J]. Theranostics, 2020, 10(5): 2141. doi: 10.7150/thno.38704
[15] SHIBANUMA M, INOUE A, USHIDA K, et al. Importance of mitochondrial dysfunction in oxidative stress response: A comparative study of gene expression profiles[J]. Free Radic Res, 2011, 45(6): 672. doi: 10.3109/10715762.2011.564169
[16] HUANG S, WANG J, CUI Y. 2, 2', 4, 4'-Tetrabromodiphenyl ether injures cell viability and mitochondrial function of mouse spermatocytes by decreasing mitochondrial proteins Atp5b and Uqcrc1[J]. Environ Toxicol Pharmacol, 2016, 46: 301. doi: 10.1016/j.etap.2016.08.011
[17] YI T, WU X, LONG Z, et al. Overexpression of Ubiquinol-Cytochrome c Reductase Core Protein 1 May Protect H9c2 Cardiac Cells by Binding with Zinc[J]. Biomed Res Int, 2017, 2017: 1314297.
[18] ZHU Y, DEAN AE, HORIKOSHI N, et al. Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy[J]. J Clin Invest, 2018, 128(9): 3682. doi: 10.1172/JCI120844
[19] GUERRA F, ARBINI AA, MORO L. Mitochondria and cancer chemoresistance[J]. Biochim Biophys Acta Bioenerg, 2017, 1858(8): 686. doi: 10.1016/j.bbabio.2017.01.012
[20] ZONG WX, RABINOWITZ JD, WHITE E. Mitochondria and Cancer[J]. Mol Cell, 2016, 61(5): 667. doi: 10.1016/j.molcel.2016.02.011
[21] IDELCHIK MDPS, BEGLEY U, BEGLEY TJ, et al. Mitochondrial ROS control of cancer[J]. Semin Cancer Biol, 2017, 47: 57. doi: 10.1016/j.semcancer.2017.04.005
[22] YANG S, LIAN G. ROS and diseases: role in metabolism and energy supply[J]. Mol Cell Biochem, 2020, 467(1/2): 1. doi: 10.1007/s11010-020-03697-8
[23] ZHUANG J, PAN ZJ, LI MQ, et al. BDE-47 induced apoptosis in zebrafish embryos through mitochondrial ROS-mediated JNK signaling[J]. Chemosphere, 2020, 258: 127385. doi: 10.1016/j.chemosphere.2020.127385
[24] MOLONEY JN, COTTER TG. ROS signalling in the biology of cancer[J]. Semin Cell Dev Biol, 2018, 80: 50. doi: 10.1016/j.semcdb.2017.05.023
[25] LI W, WUBULIKASIMU G, ZHAO X, et al. UQCRC1 downregulation is correlated with lymph node metastasis and poor prognosis in CRC[J]. Eur J Surg Oncol, 2019, 45(6): 1005. doi: 10.1016/j.ejso.2019.02.025
[26] ZONG S, LI H, SHI Q, et al. Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis[J]. Clin Chim Acta, 2016, 458: 106. doi: 10.1016/j.cca.2016.04.037
[27] LEE JH, LEE SW. The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches[J]. Gastroenterol Res Pract, 2017, 2017: 7521987.
[28] 孙磊, 张守永, 广圣芳, 等. CA153、CEA与细针吸取细胞学联合检测在乳腺癌诊断中的价值[J]. 蚌埠医学院学报, 2018, 43(3): 391.
[29] 曾艳, 张力, 贺帅. 结直肠癌患者血清CEA和CA19-9水平与肝转移的关系[J]. 癌症进展, 2019, 17(13): 1586.
[30] 赵建峰, 李记彬, 石刚, 等. 结直肠癌AIM2和血清CEA表达水平及其临床意义[J]. 中华结直肠疾病电子杂志, 2019, 8(3): 257. doi: 10.3877/cma.j.issn.2095-3224.2019.03.009